UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 自動血液分析装置automated hematology instrumentation [show details]
…light scatter regions) are measured. The DxH 800 captures five laser light scatter measurements for each cell, in contrast to one light scatter measurement for the LH750/780. The IRF is then the ratio of… were found in a smaller intermediate size peak between 90 and 160 fL; The presence of abnormal cells obscured the valleys between these three peaks,…
2. 血小板機能検査platelet function testing [show details]
… the number of red blood cell events (RBC ratio) and then multiplying this ratio by the RBC count provided by a suitably calibrated impedance analyzer.… in which platelets are identified by their light scattering properties or via fluorescence following addition of a suitable dye .… Monitoring of receptor blockade is thus becoming crucial in order to ensure optimal dosing and maximal clinical benefit for individual patients…
3. トリメトプリムスルファメトキサゾール：概要trimethoprim sulfamethoxazole an overview [show details]
… when the TMP-SMX concentration ratio is 1:20. The drug combination is prepared in a higher fixed ratio of 1:5; however, peak serum concentrations of 1:20… Dosing of TMP-SMX is based on the trimethoprim component and expressed as a mg/kg per day of TMP. Oral doses of TMP-SMX are usually given…
4. アシクロビル：概要acyclovir an overview [show details]
… decreases with higher doses. As an example, multiple oral doses of 200 to 800 mg yield steady-state peak plasma concentrations of 0.6 to 1.6 mcg/mL, whereas intravenous dosing at 5 to 10 mg/kg… higher affinity for viral DNA polymerase than for the cellular homolog, yielding a high therapeutic ratio . In descending order of susceptibility, acyclovir is active against HSV types 1 and 2 (HSV-1, HSV-2) …
5. 小児や青年の不眠症への薬物療法：エビデンスに基づいた治療法pharmacotherapy for insomnia in children and adolescents a rational approach [show details]
… of action within one hour and peak effects at two to four hours. Tolerance often develops, which may necessitate dose escalation.… confidence in the overall estimation of risk-to-benefit ratio is low .…